Rajeev Singh - 16 Jul 2022 Form 4 Insider Report for Accolade, Inc.

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
19 Jul 2022, 09:20:07 UTC
Prior SEC filing
01 Jul 2022
Next SEC filing
04 Aug 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Richard Eskew, Attorney-in-Fact

Key filing fact

Rajeev Singh filed Form 4 for Accolade, Inc. on 19 Jul 2022.

Key facts

  • This page summarizes Rajeev Singh's Form 4 filing for Accolade, Inc..
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 19 Jul 2022, 09:20.

Change

  • Previous filing in this sequence was filed on 01 Jul 2022.
  • Current net transaction value: -$2,107.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ACCD transaction

Common Stock

Options Exercise

Transaction value
Shares
+932
Change %
+1.7%
Price
Shares after
55,424
Date
16 Jul 2022
Ownership
Direct
Footnotes
F1
ACCD transaction

Common Stock

Sale

Transaction value
$2,107
Shares
-222
Change %
-0.4%
Price
$9.49
Shares after
55,202
Date
18 Jul 2022
Ownership
Direct
Footnotes
F2
ACCD holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
651,619
Date
16 Jul 2022
Ownership
By Avanti Holdings, LLC
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ACCD transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-932
Change %
-2.8%
Price
$0.000000
Shares after
32,650
Date
16 Jul 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
932
Exercise price
Footnotes
F4, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. 25% of the RSUs vested on June 16, 2022, and additional RSUs will vest monthly thereafter provided that the Reporting Person remains in continuous service on each vesting date. Unless otherwise provided, on each vesting date shares of Common Stock will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction.

Footnote F2

The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "mandatory sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Footnote F3

The Reporting Person is a partner of Avanti Holdings, LLC and has voting and investment power with respect to the securities held by Avanti Holdings, LLC.

Footnote F4

Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Footnote F5

The shares subject to this RSU shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of June 16, 2021 (the "June 2021 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the June 2021 Vesting Commencement Date thereafter for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the June 2021 Vesting Commencement Date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .